R01 CA260857/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2021	2
2022	11
2023	9
2024	4

1

Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy.

Xiao Y, Chen J, Zhou H, Zeng X, Ruan Z, Pu Z, Jiang X, Matsui A, Zhu L, Amoozgar Z, Chen DS, Han X, Duda DG, Shi J. Xiao Y, et al. Nat Commun. 2022 Feb 9;13(1):758. doi: 10.1038/s41467-022-28279-8. Nat Commun. 2022. PMID: 35140208 Free PMC article.

2

Fluorescence lifetime of injected indocyanine green as a universal marker of solid tumours in patients.

Pal R, Lwin TM, Krishnamoorthy M, Collins HR, Chan CD, Prilutskiy A, Nasrallah MP, Dijkhuis TH, Shukla S, Kendall AL, Marshall MS, Carp SA, Hung YP, Shih AR, Martinez-Lage M, Zukerberg L, Sadow PM, Faquin WC, Nahed BV, Feng AL, Emerick KS, Mieog JSD, Vahrmeijer AL, Rajasekaran K, Lee JYK, Rankin KS, Lozano-Calderon S, Varvares MA, Tanabe KK, Kumar ATN. Pal R, et al. Nat Biomed Eng. 2023 Dec;7(12):1649-1666. doi: 10.1038/s41551-023-01105-2. Epub 2023 Oct 16. Nat Biomed Eng. 2023. PMID: 37845517

3

Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy.

Chen J, Amoozgar Z, Liu X, Aoki S, Liu Z, Shin SM, Matsui A, Hernandez A, Pu Z, Halvorsen S, Lei PJ, Datta M, Zhu L, Ruan Z, Shi L, Staiculescu D, Inoue K, Munn LL, Fukumura D, Huang P, Sassi S, Bardeesy N, Ho WJ, Jain RK, Duda DG. Chen J, et al. Cancer Immunol Res. 2024 Apr 2;12(4):400-412. doi: 10.1158/2326-6066.CIR-23-0486. Cancer Immunol Res. 2024. PMID: 38260999 Free PMC article.

4

Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma.

Kikuchi H, Matsui A, Morita S, Amoozgar Z, Inoue K, Ruan Z, Staiculescu D, Wong JS, Huang P, Yau T, Jain RK, Duda DG. Kikuchi H, et al. J Natl Cancer Inst. 2022 Sep 9;114(9):1301-1305. doi: 10.1093/jnci/djac051. J Natl Cancer Inst. 2022. PMID: 35288743 Free PMC article.

5

Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.

Chamseddine S, Mohamed YI, Lee SS, Yao JC, Hu ZI, Tran Cao HS, Xiao L, Sun R, Morris JS, Hatia RI, Hassan M, Duda DG, Diab M, Mohamed A, Nassar A, Datar S, Amin HM, Kaseb AO. Chamseddine S, et al. Oncology. 2023;101(11):730-737. doi: 10.1159/000531870. Epub 2023 Aug 23. Oncology. 2023. PMID: 37467732 Free PMC article.

6

Fluorescent nanodiamond - hyaluronate conjugates for target-specific molecular imaging.

Han HH, Kang H, Kim SJ, Pal R, Kumar ATN, Choi HS, Hahn SK. Han HH, et al. RSC Adv. 2021 Jun 29;11(37):23073-23081. doi: 10.1039/d1ra03936a. eCollection 2021. RSC Adv. 2021. PMID: 34262698 Free PMC article.

7

Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences.

Chen S, Huang C, Liao G, Sun H, Xie Y, Liao C, Wang J, He M, Hu H, Dai Z, Ren X, Zeng X, Lin Z, Zhang GP, Xie W, Shen S, Li S, Peng S, Kuang DM, Zhao Q, Duda DG, Kuang M. Chen S, et al. Gut. 2023 Jun;72(6):1196-1210. doi: 10.1136/gutjnl-2022-328428. Epub 2023 Jan 3. Gut. 2023. PMID: 36596711

8

A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment.

Duda D, Gkika E, Firat E, Adebahr S, Graf E, Eichhorst A, Radicioni G, Lo S, Spohn S, Nestle U, Nicolay N, Niedermann G, Grosu AL. Duda D, et al. Res Sq [Preprint]. 2023 Nov 14:rs.3.rs-3547043. doi: 10.21203/rs.3.rs-3547043/v1. Res Sq. 2023. PMID: 38014120 Free PMC article. Preprint.

9

First Clinical Results of Fluorescence Lifetime-enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes.

Pal R, Hom ME, van den Berg NS, Lwin TM, Lee YJ, Prilutskiy A, Faquin W, Yang E, Saladi SV, Varvares MA, Rosenthal EL, Kumar ATN. Pal R, et al. Clin Cancer Res. 2022 Jun 1;28(11):2373-2384. doi: 10.1158/1078-0432.CCR-21-3429. Clin Cancer Res. 2022. PMID: 35302604 Free PMC article.

10

Comparison of fluorescence lifetime and multispectral imaging for quantitative multiplexing in biological tissue.

Pal R, Kumar ATN. Pal R, et al. Biomed Opt Express. 2022 Jun 9;13(7):3854-3868. doi: 10.1364/BOE.459935. eCollection 2022 Jul 1. Biomed Opt Express. 2022. PMID: 35991924 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year